Physician profile
James G Harper
NPI 1396866273
$41,547.05
in general payments reported to CMS, 2019-2025
21 companies · $30K in 2025
The $30K reported for 2025 was more than what 97% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $612 · 2020: $959 · 2021: $1,289 · 2022: $2,242 · 2023: $4,035 · 2024: $2,418 · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Travel and Lodging: $7,113 · Food and Beverage: $4,984 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,747.93 |
| Travel and Lodging | $7,113.13 |
| Food and Beverage | $4,984.14 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $34,037.41 | 2023-2025 | |
| Musculoskeletal Transplant Foundation INC. | $3,022.39 | 2019-2025 | |
| Allergan, INC. | $1,253.35 | 2019-2022 | |
| Mentor Worldwide LLC | $1,021.62 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Rti Surgical, INC | $422.38 | 2021-2023 | |
| Sientra, INC. | $362.25 | 2022 | |
| Integra Lifesciences Corporation | $334.17 | 2020-2024 | Integra, Surgimend, Omnigraft |
| Galderma Laboratories, L.P. | $222.98 | 2021 | |
| Tepha INC | $156.99 | 2019 | |
| Kci USA, INC. | $122.97 | 2019 | |
| Davol INC. | $109.54 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $75.00 | 2022-2023 | Seglentis |
| Tela Bio, INC. | $74.38 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Axogen | $67.98 | 2025 | |
| Baxter Healthcare | $67.86 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solta Medical, A Division of Bausch Health US, LLC | $62.30 | 2022-2025 | |
| Acelrx Pharmaceuticals, INC. | $33.78 | 2020 | |
| Biotissue Holdings INC. | $33.38 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $31.05 | 2025 | Exparel |
| Convatec INC. | $20.10 | 2021 | |
| Smith+Nephew, INC. | $15.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Harper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.